First of all, how does Khazanah get into owning so many hospitals so fast?
- Started off with a controlling stake in Pantai Hospital Group when there were complaints of Parkway acquiring strategic hospital assets in Malaysia. As a result, Khazanah was used to purchase an effective 60% stake of Pantai Hospitals from Parkway. Hence Khazanah started off with owning all the Pantai(s) in Malaysia.
- Instead of just expanding its list of private hospitals in Malaysia, Khazanah started to accrue many more hospitals overseas hence turning itself into the 2nd largest group. In its acquisition of Parkway in Singapore, Khazanah had to fend off controlling ownership and later buyoff the Group from the Fortis Group of India. Price: USD3.3billion (RM10.56 billion) at valuation of 39x PE based on Parkway's financial results for 2009.
- Latest round of acquisition, the IHH group under Khazanah bought into 60% of Acibadem group at valuation of between USD1.1 billion to RM1.68 billion depending on which group they bought from. Based on my calculation, the valuation on Acibadem is in excess of 15x EBITDA and more than 100x PE. Even if it is calculated at Price / Book Value it is more than 14x book value.
- On top of that, Khazanah already owns 12.2% of Apollo Hospitals which it acquired as an investment in 2005.
Financials of Acibadem before the acquisition from IHH |
Hence, despite Khazanah managed to accumulate that many hospitals, it is at the expense of very high price being paid for these assets.
Latest Structure for the IHH Group |
Although the proforma financials for IHH is not yet available, based on my estimation from past financials here are possible contributions from each.
I hope I am wrong for this one!
--------------------------------------------------------------------------------------------
(Note that the combined valuation of Parkway and Acibadem were USD4.4 billion (RM14 billion) when they were taken private. How much do you think the listed IHH would be? Would Khazanah be willing to take a valuation cut if it is going for RM15 billion or less? Hence the question, is Khazanah that desperate to sell?)
Anyway, is the term 2nd largest misleading as it only owns 12.2% of Apollo?
Note:
Despite all the positiveness, the business of private healthcare which has a great advantage i.e. its pricing inelasticity is facing greater competition in future. I still like the IHH private healthcare group though as a business but the issue here is price. Frankly, I do not see the need to rush this IPO. If Khazanah is not valuing the IPO at in excess of RM15 billion, why do they need to let go part of the group at a lower price especially when the purchases were made at a high price. They could have waited it out and do the IPO by 2013 or 2014. I do not believe this is a political IPO either unlike the Felda IPO which they need to be quick.
Other article on IHH IPO:
IHH IPO: Where's the beef?
No comments:
Post a Comment